Cronos (CRON) Net Cash Flow Growth (1y) (2020 - 2026)
Cronos (CRON) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | -1,020.00% |
| 10 | Cronos | 1.08 Bn | 259.36 Mn | 19.15 Mn | 150.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150.78% |
| Dec 31, 2025 | 202.91% |
| Sep 30, 2025 | -207.51% |
| Jun 30, 2025 | 17.28% |
| Mar 31, 2025 | -132.34% |
| Dec 31, 2024 | -97.59% |
| Sep 30, 2024 | -93.17% |
| Jun 30, 2024 | -1.55% |
| Mar 31, 2024 | 153.00% |
| Dec 31, 2023 | -26.21% |
| Sep 30, 2023 | 217.78% |
| Jun 30, 2023 | 88.25% |
| Mar 31, 2023 | -927.71% |
| Dec 31, 2022 | 195.79% |
| Sep 30, 2022 | -239.01% |
| Jun 30, 2022 | 56.63% |
| Mar 31, 2022 | 47.27% |
| Dec 31, 2021 | 179.57% |
| Sep 30, 2021 | -21.32% |
| Jun 30, 2021 | -134.36% |